发明名称 |
DOSING REGIMES FOR THE TREATMENT OF OCULAR VASCULAR DISEASE |
摘要 |
The use of vascular endothelial growth factor receptor 2 inhibitors or a pharmaceutically acceptable salt thereof for the treatment of ocular vascular disease is provided. Dosing regimes, including once weekly administration, of certain VEGF-R2 inhibitors are provided which deliver therapeutically effective concentrations of the VEGF-R2 compounds in ocular tissues for at least one week for the treatment of ocular vascular disease. |
申请公布号 |
KR20140008303(A) |
申请公布日期 |
2014.01.21 |
申请号 |
KR20137010744 |
申请日期 |
2011.10.25 |
申请人 |
NOVARTIS AG |
发明人 |
BRIGELL MITCHELL;END PETER;HOSAGRAHARA VINAYAK;JAFFEE BRUCE;MEREDITH ERIK;NEWTON RONALD;POOR STEPHEN;QIU YUBIN |
分类号 |
A61K31/404;A61K31/4709;A61K31/505;A61K31/506;A61P27/02 |
主分类号 |
A61K31/404 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|